Medical, dental, and specialty practices
Medical and dental practices: patient data should not leave on an unapproved AI tool.
Front desks adopt tools faster than anyone writes a rule. We take the technology leadership role: spend, vendors, and reporting across sites. The patient-data rule is part of that role. We do not run the clinic help desk.
Typical setup for this industry. Not a client count.
The setup
What we usually find in medical, dental, and specialty practices.
A multi-site practice collects tools quietly. A transcription app one clinician likes, a scheduling add-on the office manager found, an unapproved AI tool the front desk uses to make a letter sound better. Each one is reasonable on its own, and none of them were reviewed together.
Meanwhile the reporting that would settle an argument about capacity, no-shows, or collections lives in practice management, scheduling, and billing. Someone merges the three by hand every month.
What leadership gets
Three reports worth having first.
- ✓Visits, capacity, and no-shows by site, provider, and appointment type
- ✓Billing, collections, and overdue balances by age, with the denial reasons worth fixing
- ✓Payer mix and reimbursement trend, read the same way every month
Report names are typical for the industry. Yours come from the systems the applications assessment finds. The base dashboard also shows what your technology costs, so license and vendor spend sits beside the operating numbers.
The method, in your terms
How the work usually runs.
- AI Use Policy adopted with a hard patient-data rule and a named exception owner
- AI security assessment confirms what is in use across every site and closes what is not allowed
- Transcription and clinical tools reviewed rather than banned, with logging switched on
- Applications assessment maps practice management, scheduling, and billing
- Base dashboard set up in the practice's Microsoft cloud account, reporting across sites
- AI security subscription and monthly watch to enforce and report the rule
The order is fixed. Where you start is a decision, and the first meeting is where it gets made.
Where this has run
A profile from this industry.
Patient data was being entered into a public AI tool.
Multi-site healthcare practice · ~60 staff
Patient data set the order. The policy and the assessment came before any connection, the unapproved tools were closed first, and the dashboard went live only for the systems the policy cleared.
Start here
What this industry buys first.
- AI Use Policy · Advisory review
- AI security & governance assessment · Advisory review
- AI security features · Monthly watch
- Base dashboard deployment · Deployment
- Applications assessment · Assessment
- Copilot readiness · Delivery · scoped from the review
Where we work
Medical, dental, and specialty practices firms across the Carolinas.
Questions
Questions from medical, dental, and specialty practices
Do we have to ban clinical AI tools?
No, you do not have to ban clinical AI tools. Most can be approved with the right logging, retention, and access settings. The AI Use Policy sets what may touch patient data and what may not. Every tool already in use gets a clear decision: keep it, change how it is used, or retire it.
Is this HIPAA compliance?
This is the technology and oversight half of HIPAA compliance: the policy, the access controls, the logging, the reporting, and the evidence behind them. Third Shift is not your compliance officer and not your lawyer, and we say that in writing. The obligations and the clinical judgment stay yours.
Will this interfere with our EHR or practice management system?
No, this will not interfere with your EHR or practice management system. Third Shift reads from those systems rather than replacing them, and only where they offer a connection or a scheduled export. Clinical workflow stays exactly where it is, and the content of patient records is never touched.
Start here
The first step is the same in every industry.
Advisory first: a written assessment of your environment, the AI Use Policy, and a recommendation you own whether or not you continue with us.